Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Abstract Cancer, characterized by its immune evasion, active metabolism, and heightened proliferation, comprises both stroma and cells. Although the research has always focused on parenchymal cells, the non-parenchymal components must not be overlooked. Targeting cancer parenchymal cells has proven...
Saved in:
| Main Authors: | Keke Lv, Tianlin He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Molecular Biomedicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43556-024-00233-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential of tumour mechanotargeting in lung cancer therapeutics
by: Kostas A. Papavassiliou, et al.
Published: (2025-12-01) -
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01) -
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
by: Zhang Z, et al.
Published: (2025-01-01) -
Promotion Mechanisms of Stromal Cell-Mediated Lung Cancer Development Within Tumor Microenvironment
by: Wu S, et al.
Published: (2025-02-01) -
Extracellular Vesicles from Lung Adenocarcinoma Cells Induce Activation of Different Cancer-Associated Fibroblast Subtypes
by: Jessica Angelina Trejo Vazquez, et al.
Published: (2024-11-01)